GE Healthcare, Lantheus begin Flurpiridaz trial to detect coronary artery disease

Image: GE Healthcare and Lantheus have started a second Phase 3 clinical trial of Flurpiridaz to detect coronary artery disease. Photo: courtesy of Photo by Robina Weermeijer / Unsplash.